Atlas Venture Advisors, Inc. - Q3 2021 holdings

$845 Million is the total value of Atlas Venture Advisors, Inc.'s 8 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 11.1% .

 Value Shares↓ Weighting
IAS  INTEGRAL AD SCIENCE HLDNG CO$468,772,000
+0.2%
22,722,7700.0%55.51%
+14.4%
DKNG SellDRAFTKINGS INC$315,718,000
-16.9%
6,555,608
-10.0%
37.38%
-5.2%
SNAP  SNAP INCcl a$18,139,000
+8.4%
245,5590.0%2.15%
+23.7%
ROKU  ROKU INC$18,082,000
-31.8%
57,7070.0%2.14%
-22.2%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$12,797,000
+37.0%
307,6960.0%1.52%
+56.2%
FSTX  F-STAR THERAPEUTICS INC$4,209,000
-14.8%
574,9960.0%0.50%
-2.9%
VRDN  VIRIDIAN THERAPEUTICS INC$3,446,000
-10.1%
209,5050.0%0.41%
+2.5%
LRMR  LARIMAR THERAPEUTICS INC$3,369,000
+17.4%
292,1840.0%0.40%
+33.9%
TBIO ExitTRANSLATE BIO INC$0-1,872,115
-100.0%
-5.35%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-04
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SNAP INC20Q3 20236.1%
ROKU INC16Q3 202311.7%
LARIMAR THERAPEUTICS INC14Q3 20231.4%
TRANSLATE BIO INC11Q2 202152.9%
INTEGRAL AD SCIENCE HLDNG CO10Q3 202371.2%
BICYCLE THERAPEUTICS PLC10Q3 202125.2%
VIRIDIAN THERAPEUTICS INC10Q1 20232.1%
F-STAR THERAPEUTICS INC9Q4 20221.3%
DRAFTKINGS INC8Q1 202282.5%
MIRAGEN THERAPEUTICS INC8Q3 20205.0%

View Atlas Venture Advisors, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04

View Atlas Venture Advisors, Inc.'s complete filings history.

Compare quarters

Export Atlas Venture Advisors, Inc.'s holdings